Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. BioNTech SE
  6. News
  7. Summary
    BNTX   US09075V1026

BIONTECH SE

(BNTX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

European ADRs Down Nearly 3% Friday as Travel, Energy, Financial Shares Slump

11/26/2021 | 11:12am EST


© MT Newswires 2021
All news about BIONTECH SE
12:28pUBS Adjusts BioNTech SE Price Target to $170 From $300, Maintains Neutral Rating
MT
11:56aPfizer-BioNTech's COVID-19 Vaccine Gets WHO Backing for Kids 5 to 11 Years Old
MT
11:11aEuropean ADRs Move Lower in Friday Trading
MT
10:26aJapan OKs Pfizer/BioNTech's COVID-19 Vaccine For Children
MT
04:30aJapan Clears Use of Pfizer's COVID-19 Vaccine on Children
MT
01/20EUROPEAN MIDDAY BRIEFING - Stocks Down After Mixed Asia Trading, US Fall
DJ
01/20Canadian Biotech Disruptor Lexston Life Sciences is unlocking the God Molecule (LEXTF, ..
AQ
01/19BIONTECH : Goldman Sachs sticks Neutral
MD
01/18Fourth Pfizer-BioNTech COVID-19 Shot Fails to Prevent Omicron Infection in Israeli Stud..
MT
01/18Morgan Stanley Adjusts BioNTech's Price Target to $284 from $294, Keeps Equalweight Rat..
MT
More news
Analyst Recommendations on BIONTECH SE
More recommendations
Financials
Sales 2021 17 454 M 19 793 M 19 793 M
Net income 2021 9 220 M 10 455 M 10 455 M
Net cash 2021 8 918 M 10 113 M 10 113 M
P/E ratio 2021 3,54x
Yield 2021 -
Capitalization 31 415 M 35 624 M 35 624 M
EV / Sales 2021 1,29x
EV / Sales 2022 0,76x
Nbr of Employees 2 800
Free-Float -
Chart BIONTECH SE
Duration : Period :
BioNTech SE Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BIONTECH SE
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 16
Last Close Price 130,07 €
Average target price 263,70 €
Spread / Average Target 103%
EPS Revisions
Managers and Directors
Ugur Sahin Chief Executive Officer
Jens Holstein Chief Financial Officer
Helmut Jeggle Chairman-Supervisory Board
Özlem Türeci Chief Medical Officer
Sierk Pötting Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
BIONTECH SE-42.79%37 805
GILEAD SCIENCES, INC.-6.61%85 060
REGENERON PHARMACEUTICALS-2.71%64 237
VERTEX PHARMACEUTICALS4.10%58 125
WUXI APPTEC CO., LTD.-9.18%51 206
BEIGENE, LTD.-7.22%25 827